IMRX / Immuneering Corporation - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Immuneering Corporation
US ˙ NasdaqGM ˙ US45254E1073

Deler fremragende 64,697,227 shares
Insideraktier9.036.958 shares
Insider ejerskab13,97 %
Total Insiders16
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
4921 out of 10953

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
4879 out of 10834

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Immuneering Corporation insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Biren Amin CFO, TREASURER - [O] 7.898 7.898
Ann E Berman Director - [D] 67.465 67.465
Scott Barrett CHIEF MEDICAL OFFICER - [O] 7.563 7.563
Michael Bookman CHIEF LEGAL OFFICER, SECRETARY - [O] 4.870 4.870
Harold Eugene Brakewood Chief Business Officer - [O] 11.050 11.050
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Robert J Carpenter Director - [D] 1.148.839 1.148.839
Cormorant Asset Management, LLC 10% Owner - [10%] 2.895.273 2.895.273
Cormorant Private Healthcare Fund III LP 10% Owner - [10%] 2.252.628 2.895.273
Peter Feinberg Director - [D] 1.161.064 1.161.064
Diana Hausman Director - [D] 3.000 3.000
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Brett Matthew Hall CHIEF SCIENTIFIC OFFICER - [O] 376.496 376.496
Laurie Keating Director - [D] 14.000 14.000
Mallory Morales Chief Accounting Officer - [O] 27.533 27.533
Leah R Neufeld CHIEF PEOPLE OFFICER - [O] 29.598 29.598
Schall Thomas J. Director - [D] 74.530 74.530
Zeskind Benjamin J. PRESIDENT AND CEO, Director, 10% Owner - [D] [O] [10%] 3.207.779 3.207.779

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i IMRX / Immuneering Corporation. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2026-01-16 Brakewood Harold Eugene 5.250 4,7600 5.250 4,7600 24.990 97 6.1300 7.192 28,78
2026-01-15 Schall Thomas J. 21.645 4,6681 21.645 4,6681 101.041
2026-01-15 Hall Brett Matthew 2.298 4,5700 2.298 4,5700 10.502
2026-01-13 Neufeld Leah R 2.626 4,1530 2.626 4,1530 10.906
2026-01-12 Feinberg Peter 20.000 4,3452 20.000 4,3452 86.904
2025-10-03 Feinberg Peter 7.500 6,6700 7.500 6,6700 50.025
2025-10-01 Neufeld Leah R 800 6,3792 800 6,3792 5.103
2025-10-01 Bookman Michael 1.020 6,8299 1.020 6,8299 6.966
2025-10-01 Morales Mallory 300 6,3900 300 6,3900 1.917

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

IMRX / Immuneering Corporation Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i IMRX / Immuneering Corporation. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2024-04-01 Cormorant Asset Management, LLC 398.600 2,9000 398.600 2,9000 1.155.940 137 1.0300 -745.382 -64,48
2024-04-01 Cormorant Asset Management, LLC 280 2,9700 280 2,9700 832
2024-04-01 Cormorant Asset Management, LLC 10 2,9800 10 2,9800 30
2024-04-01 Cormorant Asset Management, LLC 10 3,0100 10 3,0100 30
2024-04-01 Cormorant Asset Management, LLC 600 3,0300 600 3,0300 1.818
2024-04-01 Cormorant Asset Management, LLC 100 3,0500 100 3,0500 305
2024-04-01 Cormorant Asset Management, LLC 300 3,0650 300 3,0650 920
2024-04-01 Cormorant Asset Management, LLC 100 3,0700 100 3,0700 307
2024-03-15 Cormorant Asset Management, LLC 400.000 2,1410 400.000 2,1410 856.400

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

IMRX / Immuneering Corporation Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2026-03-17 2026-03-13 4 Neufeld Leah R IMRX Class A Common Stock A - Award D 4,2925 3.628 16 29.598
2026-01-21 2026-01-16 4 Brakewood Harold Eugene IMRX Class A Common Stock P - Purchase D 4,7600 5.250 25 11.050
2026-01-20 2026-01-15 4 Schall Thomas J. IMRX Class A Common Stock P - Purchase D 4,6681 21.645 101 74.530
2026-01-16 2026-01-15 4 Hall Brett Matthew IMRX Class A Common Stock P - Purchase D 4,5700 2.298 11 376.496
2026-01-15 2026-01-13 4 Neufeld Leah R IMRX Class A Common Stock P - Purchase D 4,1530 2.626 11 25.970
2026-01-14 2026-01-12 4 Feinberg Peter General Partner of S4K Investments LLC. IMRX Class A Common Stock P - Purchase I 4,3452 20.000 87 135.441
2025-10-07 2025-10-03 4 Feinberg Peter IMRX Class A Common Stock P - Purchase D 6,6700 7.500 50 156.766
2025-10-02 2025-10-01 4 Morales Mallory IMRX Class A Common Stock P - Purchase D 6,3900 300 2 27.533
2025-10-02 2025-10-01 4 Neufeld Leah R IMRX Class A Common Stock P - Purchase D 6,3792 800 5 23.344
2025-10-02 2025-10-01 4 Bookman Michael IMRX Class A Common Stock P - Purchase D 6,8299 1.020 7 4.870
2025-10-01 2025-09-30 4 Feinberg Peter IMRX Class A Common Stock P - Purchase D 7,0307 7.500 53 149.266
2025-09-30 2025-09-29 4 Feinberg Peter IMRX Class A Common Stock P - Purchase D 7,1800 5.000 36 141.766
2025-09-17 2025-09-15 4 Neufeld Leah R IMRX Class A Common Stock A - Award D 1,4280 11.815 17 22.544
2025-09-17 2025-09-15 4 Morales Mallory IMRX Class A Common Stock A - Award D 1,4280 14.497 21 27.233
2025-09-17 2025-09-15 4 Hall Brett Matthew IMRX Class A Common Stock A - Award D 1,4280 14.880 21 374.198
2025-07-07 2025-07-02 4 HAUSMAN DIANA By spouse IMRX Class A Common Stock P - Purchase I 3,6245 3.000 11 3.000
2025-07-07 2025-07-02 4 HAUSMAN DIANA IMRX Class A Common Stock P - Purchase D 3,5956 2.500 9 2.500
2025-07-07 2025-07-02 4 Neufeld Leah R IMRX Class A Common Stock P - Purchase D 3,5695 700 2 10.729
2025-07-03 2025-07-02 4 Zeskind Benjamin J. IMRX Class A Common Stock P - Purchase D 3,5342 7.015 25 2.312.852
2025-07-03 2025-07-01 4 Zeskind Benjamin J. IMRX Class A Common Stock P - Purchase D 3,3792 2.985 10 2.305.837
2025-06-30 2025-06-27 4 Schall Thomas J. IMRX Class A Common Stock P - Purchase D 3,6619 9.500 35 52.885
2025-06-24 2025-06-23 4 Hall Brett Matthew IMRX Class A Common Stock P - Purchase D 2,4299 6.007 15 359.318
2025-06-24 2025-06-20 4 Hall Brett Matthew IMRX Class A Common Stock P - Purchase D 2,6999 7.415 20 353.311
2025-06-24 2025-06-20 4 Brakewood Harold Eugene IMRX Class A Common Stock P - Purchase D 2,5285 1.900 5 5.800
2025-06-23 2025-06-18 4 Feinberg Peter IMRX Class A Common Stock P - Purchase D 2,5275 25.000 63 136.766
2025-06-20 2025-06-18 4 Zeskind Benjamin J. IMRX Class A Common Stock P - Purchase D 2,3878 21.000 50 2.302.852
2025-06-18 2025-06-17 4 Schall Thomas J. IMRX Class A Common Stock P - Purchase D 2,2052 40.485 89 43.385
2024-09-17 2024-09-15 4 Morales Mallory IMRX Class A Common Stock A - Award D 1,6235 4.458 7 12.736
2024-04-03 2024-04-01 4 Cormorant Asset Management, LLC IMRX Class A Common Stock S - Sale I 2,9000 -398.600 -1.156 2.895.273
2024-04-03 2024-04-01 4 Cormorant Asset Management, LLC IMRX Class A Common Stock S - Sale I 2,9700 -280 -1 3.293.873
2024-04-03 2024-04-01 4 Cormorant Asset Management, LLC IMRX Class A Common Stock S - Sale I 2,9800 -10 -0 3.294.153
2024-04-03 2024-04-01 4 Cormorant Asset Management, LLC IMRX Class A Common Stock S - Sale I 3,0100 -10 -0 3.294.163
2024-04-03 2024-04-01 4 Cormorant Asset Management, LLC IMRX Class A Common Stock S - Sale I 3,0300 -600 -2 3.294.173
2024-04-03 2024-04-01 4 Cormorant Asset Management, LLC IMRX Class A Common Stock S - Sale I 3,0500 -100 -0 3.294.773
2024-04-03 2024-04-01 4 Cormorant Asset Management, LLC IMRX Class A Common Stock S - Sale I 3,0650 -300 -1 3.294.873
2024-04-03 2024-04-01 4 Cormorant Asset Management, LLC IMRX Class A Common Stock S - Sale I 3,0700 -100 -0 3.295.173
2024-03-25 2024-03-22 4 Schall Thomas J. IMRX Class A Common Stock P - Purchase D 2,5465 2.900 7 2.900
2024-03-25 2024-03-22 4 Feinberg Peter IMRX Class A Common Stock P - Purchase D 2,5485 25.000 64 111.766
2024-03-25 2024-03-22 4 Brakewood Harold Eugene IMRX Class A Common Stock P - Purchase D 2,5680 3.900 10 3.900
2024-03-25 2024-03-22 4 Morales Mallory IMRX Class A Common Stock P - Purchase D 2,5455 393 1 8.278
2024-03-25 2024-03-21 4 Morales Mallory IMRX Class A Common Stock P - Purchase D 2,7179 1.107 3 7.885
2024-03-25 2024-03-15 4 Morales Mallory IMRX Class A Common Stock A - Award D 1,6200 4.344 7 6.778
2024-03-21 2024-03-20 4 Neufeld Leah R IMRX Class A Common Stock P - Purchase D 2,8793 3.818 11 10.029
2024-03-21 2024-03-15 4 Neufeld Leah R IMRX Class A Common Stock A - Award D 1,6200 6.211 10 6.211
2024-03-21 2024-03-20 4 Hall Brett Matthew IMRX Class A Common Stock P - Purchase D 2,8600 7.000 20 345.896
2024-03-21 2024-03-15 4 Hall Brett Matthew IMRX Class A Common Stock A - Award D 1,6200 6.211 10 338.896
2024-03-19 2024-03-15 4 Bookman Michael IMRX Class A Common Stock A - Award D 1,6200 1.448 2 3.850
2024-03-19 2024-03-18 4 BERMAN ANN E IMRX Class A Common Stock P - Purchase D 2,1295 57.965 123 67.465
2024-03-19 2024-03-19 4 Feinberg Peter IMRX Class A Common Stock P - Purchase D 2,5600 25.000 64 86.766
2024-03-19 2024-03-18 4 Feinberg Peter IMRX Class A Common Stock P - Purchase D 3,0549 4.976 15 61.766
2024-03-19 2024-03-18 4 Feinberg Peter IMRX Class A Common Stock P - Purchase D 2,3067 45.024 104 56.790
2024-03-19 2024-03-19 4 Zeskind Benjamin J. IMRX Class A Common Stock P - Purchase D 2,7663 20.000 55 2.281.852
2024-03-18 2024-03-15 4 Cormorant Asset Management, LLC IMRX Class A Common Stock S - Sale I 2,1410 -400.000 -856 3.295.273
2024-03-18 2024-03-14 4 Cormorant Asset Management, LLC IMRX Class A Common Stock S - Sale I 5,9680 -11.040 -66 3.695.273
2024-03-18 2024-03-14 4 Cormorant Asset Management, LLC IMRX Class A Common Stock S - Sale I 5,3740 -54.215 -291 3.706.313
2024-03-18 2024-03-14 4 Cormorant Asset Management, LLC IMRX Class A Common Stock S - Sale I 4,2450 -98.570 -418 3.760.528
2024-03-18 2024-03-14 4 Cormorant Asset Management, LLC IMRX Class A Common Stock S - Sale I 3,2350 -345.266 -1.117 3.859.098
2023-04-24 3 Chen Bihua See Footnotes IMRX Class A Common Stock I 4.204.364
2022-12-27 2022-12-22 4 Zeskind Benjamin J. IMRX Class A Common Stock M - Exercise D 3,0100 2.500 8 2.261.852
2022-08-11 3 Morales Mallory IMRX Class A Common Stock D 2.434
2022-05-27 2022-05-25 4 Hall Brett Matthew IMRX Class A Common Stock P - Purchase D 3,9200 2.551 10 332.685
2022-05-18 2022-05-17 4 Bookman Michael IMRX Class A Common Stock P - Purchase D 4,8800 1.000 5 2.402
2022-05-17 2022-05-16 4 KEATING LAURIE IMRX Class A Common Stock P - Purchase D 5,0000 7.000 35 14.000
2022-05-12 2022-05-12 4 Amin Biren IMRX Class A Common Stock P - Purchase D 4,4200 1.000 4 7.898
2022-04-14 2022-04-12 4 Zeskind Benjamin J. IMRX Stock Option M - Exercise D 3,01 -2.000 206.000
2022-04-14 2022-04-12 4 Zeskind Benjamin J. IMRX Class A Common Stock M - Exercise D 3,0100 2.000 6 2.259.352
2022-03-24 2022-03-23 4 Zeskind Benjamin J. IMRX Class A Common Stock P - Purchase D 8,0200 3.000 24 2.257.352
2022-03-23 2022-03-23 4 Hall Brett Matthew IMRX Class A Common Stock P - Purchase D 7,9100 1.050 8 330.134
2022-03-22 2022-03-22 4 Barrett Scott IMRX Class A Common Stock P - Purchase D 7,4850 900 7 7.563
2022-03-16 2022-03-15 4 Feinberg Peter IMRX Class A Common Stock P - Purchase D 6,7500 6.667 45 11.766
2022-03-15 2022-03-15 4 BERMAN ANN E IMRX Class A Common Stock P - Purchase D 6,4000 6.000 38 9.500
2022-03-01 2022-02-28 4 Zeskind Benjamin J. IMRX Stock Option M - Exercise D 3,01 -2.000 208.000
2022-03-01 2022-02-28 4 Zeskind Benjamin J. IMRX Class A Common Stock M - Exercise D 3,0100 2.000 6 2.254.352
2022-02-14 2022-02-10 4 Amin Biren IMRX Stock Option A - Award D 9,66 70.050 70.050
2022-02-14 2022-02-10 4 Hall Brett Matthew IMRX Stock Option A - Award D 9,66 83.100 83.100
2022-02-14 2022-02-10 4 Barrett Scott IMRX Stock Option A - Award D 9,66 71.850 71.850
2022-02-14 2022-02-10 4 Bookman Michael IMRX Stock Option A - Award D 9,66 47.300 47.300
2022-02-14 2022-02-10 4 Zeskind Benjamin J. IMRX Stock Option A - Award D 10,63 45.615 202.100
2022-02-14 2022-02-10 4 Zeskind Benjamin J. IMRX Stock Option A - Award D 9,66 156.485 156.485
2022-02-10 2021-10-22 5 Zeskind Benjamin J. See Foonote IMRX Class A Common Stock G - Gift I 350.000 894.927
2022-02-10 2021-10-22 5 Zeskind Benjamin J. IMRX Class A Common Stock G - Gift D -350.000 2.252.352
2022-01-18 2022-01-14 4 HAUSMAN DIANA IMRX Stock Option A - Award D 13,00 13,0000 25.200 328 25.200
2021-12-22 2021-12-22 4 Hall Brett Matthew IMRX Class A Common Stock A - Award D 322.691 329.084
2021-09-21 2021-09-20 4 Feinberg Peter IMRX Class A Common Stock P - Purchase D 24,4450 4.750 116 5.099
2021-09-15 2021-09-13 4 Feinberg Peter IMRX Class A Common Stock P - Purchase D 21,2500 349 7 349
2021-09-15 2021-09-13 4 Feinberg Peter General Partner of PF Associates L.P. IMRX Class A Common Stock P - Purchase I 21,5126 5.750 124 392.242
2021-09-14 2021-09-13 4 Zeskind Benjamin J. IMRX Class A Common Stock P - Purchase D 22,8670 2.083 48 2.602.352
2021-09-13 3/A Feinberg Peter IMRX Class A Common Stock I 224.293
2021-09-13 3/A Feinberg Peter IMRX Class A Common Stock I 123.753
2021-08-05 2021-08-03 4 Cormorant Asset Management, LLC See Footnotes IMRX Series B Convertible Preferred Stock C - Conversion I -1.702.628 0
2021-08-05 2021-08-03 4 Cormorant Asset Management, LLC See Footnotes IMRX Common Stock P - Purchase I 15,0000 550.000 8.250 2.252.628
2021-08-05 2021-08-03 4 Cormorant Asset Management, LLC See Footnotes IMRX Common Stock C - Conversion I 1.702.628 1.702.628
2021-08-04 2021-08-03 4 CARPENTER ROBERT J IMRX Series B Preferred Stock C - Conversion D -122.588 0
2021-08-04 2021-08-03 4 CARPENTER ROBERT J IMRX Series A Preferred Stock C - Conversion D -94.585 0
2021-08-04 2021-08-03 4 CARPENTER ROBERT J IMRX Class A Common Stock P - Purchase D 15,0000 325.000 4.875 1.148.839
2021-08-04 2021-08-03 4 CARPENTER ROBERT J IMRX Class A Common Stock C - Conversion D 217.173 823.839
2021-08-04 2021-08-03 4 Barrett Scott IMRX Series B Preferred Stock C - Conversion D -2.723 0
2021-08-04 2021-08-03 4 Barrett Scott IMRX Series A Preferred Stock C - Conversion D -3.273 0
2021-08-04 2021-08-03 4 Barrett Scott IMRX Class A Common Stock P - Purchase D 15,0000 667 10 6.663
2021-08-04 2021-08-03 4 Barrett Scott IMRX Class A Common Stock C - Conversion D 5.996 5.996
2021-08-04 2021-08-03 4 Zeskind Benjamin J. IMRX Series B Preferred Stock C - Conversion D -8.171 0
2021-08-04 2021-08-03 4 Zeskind Benjamin J. IMRX Series A Preferred Stock C - Conversion D -40.928 0
2021-08-04 2021-08-03 4 Zeskind Benjamin J. IMRX Class A Common Stock P - Purchase D 15,0000 2.098 31 2.600.269
2021-08-04 2021-08-03 4 Zeskind Benjamin J. IMRX Class A Common Stock C - Conversion D 49.099 2.598.171
2021-08-04 2021-08-03 4 KEATING LAURIE IMRX Class A Common Stock P - Purchase D 15,0000 7.000 105 7.000
2021-08-04 2021-08-03 4 Amin Biren IMRX Series B Preferred Stock C - Conversion D -2.723 0
2021-08-04 2021-08-03 4 Amin Biren IMRX Class A Common Stock P - Purchase D 15,0000 4.175 63 6.898
2021-08-04 2021-08-03 4 Amin Biren IMRX Class A Common Stock C - Conversion D 2.723 2.723
2021-08-04 2021-08-03 4 Bookman Michael IMRX Class A Common Stock P - Purchase D 15,0000 1.402 21 1.402
2021-08-04 2021-08-03 4 Hall Brett Matthew IMRX Series B Preferred Stock C - Conversion D -3.404 0
2021-08-04 2021-08-03 4 Hall Brett Matthew IMRX Series A Preferred Stock C - Conversion D -1.636 0
2021-08-04 2021-08-03 4 Hall Brett Matthew IMRX Class A Common Stock P - Purchase D 15,0000 1.353 20 6.393
2021-08-04 2021-08-03 4 Hall Brett Matthew IMRX Class A Common Stock C - Conversion D 5.040 5.040
2021-08-04 2021-08-03 4 BERMAN ANN E IMRX Class A Common Stock P - Purchase D 15,0000 3.500 52 3.500
2021-08-04 2021-08-03 4 Feinberg Peter IMRX Series B Preferred Stock C - Conversion I -30.646 0
2021-08-04 2021-08-03 4 Feinberg Peter IMRX Series B Preferred Stock C - Conversion I -30.646 0
2021-08-04 2021-08-03 4 Feinberg Peter IMRX Series B Preferred Stock C - Conversion I -30.646 0
2021-08-04 2021-08-03 4 Feinberg Peter IMRX Series A Preferred Stock C - Conversion I -51.462 0
2021-08-04 2021-08-03 4 Feinberg Peter IMRX Series A Preferred Stock C - Conversion I -92.509 0
2021-08-04 2021-08-03 4 Feinberg Peter IMRX Series A Preferred Stock C - Conversion I -102.926 0
2021-08-04 2021-08-03 4 Feinberg Peter See Foonote IMRX Class A Common Stock P - Purchase I 15,0000 33.333 500 115.441
2021-08-04 2021-08-03 4 Feinberg Peter See Foonote IMRX Class A Common Stock C - Conversion I 82.108 82.108
2021-08-04 2021-08-03 4 Feinberg Peter See Foonote IMRX Class A Common Stock P - Purchase I 15,0000 129.167 1.938 476.568
2021-08-04 2021-08-03 4 Feinberg Peter See Foonote IMRX Class A Common Stock P - Purchase I 15,0000 129.167 1.938 476.568
2021-08-04 2021-08-03 4 Feinberg Peter See Foonote IMRX Class A Common Stock C - Conversion I 123.155 347.401
2021-08-04 2021-08-03 4 Feinberg Peter See Foonote IMRX Class A Common Stock C - Conversion I 133.572 257.325
2021-07-30 2021-07-29 4 Bookman Michael IMRX Stock Option A - Award D 15,00 -101.116 101.116
2021-07-30 2021-07-29 4 BERMAN ANN E IMRX Stock Option A - Award D 15,00 -28.371 28.371
2021-07-29 3 Feinberg Peter IMRX Class A Common Stock I 224.246
2021-07-29 3 Feinberg Peter IMRX Class A Common Stock I 123.753
2021-07-29 3 Zeskind Benjamin J. IMRX Class A Common Stock I 544.927
2021-07-29 3 Zeskind Benjamin J. IMRX Class A Common Stock D 2.549.072
2021-07-29 3 CARPENTER ROBERT J IMRX Class A Common Stock D 606.666
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista